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Introduction
Recent studies have suggested that hydrogen sulfide (H 2 S), in addition to nitric oxide (NO) and carbon monoxide (CO), is a third gaseous signal molecule in the regulation of blood pressure (Wang, 2002) . In mammals, H 2 S can be produced endogenously in mammals from L-cysteine by pyridoxal-5'-phosphate-dependent enzymes such as cystathionine β -synthase (CBS) and cystathionine γ -lyase (CSE).
The expression of these two enzymes is tissue specific (Wang, 2002) with CBS highly expressed in the brain. In addition, 3-mercaptopyruvate sulfurtransferase has been demonstrated as a H 2 S producing enzyme in the brain as well as in the vascular endothelium (Shibuya et al., 2009a; Shibuya et al., 2009b ). The endogenous levels of H 2 S in the central nervous system, which have been measured in rats, humans, and bovines Warenycia et al., 1989; Savage and Gould, 1990) , play important roles in the hippocampal long-term potentiation and regulation of N-methyl-D-aspartate (NMDA) receptors (Abe and Kimura, 1996) . Sodium hydrosulfide (NaHS) is commonly used as an H 2 S donor since it dissociates to Na + and HS -, the latter of which then partially binds H + to form undissociated H 2 S (Lowicka and Beltowski, 2007) .
H 2 S has an important role in the regulation of physiological functions including learning and memory (Kimura, 2002) and cardiovascular functions (Hosoki et al., 1997; Zhao et al., 2001; Zhao and Wang, 2002) . For example, the vasodilator effect 
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of H 2 S is mediated by K ATP channels (Hosoki et al., 1997; Zhao et al., 2001) .
Furthermore, the H 2 S signaling pathway is involved in vascular collagen remodeling in spontaneously hypertensive rats (SHRs) (Zhao et al., 2008) . In previous studies, we have shown that H 2 S increases the sensitivity of carotid sinus baroreflex by opening K ATP channels and closing of the L-Ca 2+ channels (Xiao et al., 2006; Xiao et al., 2007 ). These findings indicate that H 2 S regulates the cardiovascular homodynamic through its central effect on the baroreceptor reflex (Lowicka and Beltowski, 2007) . Furthermore, the physiological concentration of H 2 S has been shown to facilitate long-term potentiation in the hippocampus, likely through cyclic adenosine 3', 5'-monophosphate-mediated interactions with NMDA receptors (Abe and Kimura, 1996; Kimura, 2000) . However, the role of H 2 S in the autonomic centers regulating sympathetic outflow remains unknown.
Several studies' findings suggest that H 2 S interacts with NO to regulate cardiovascular function. For example, the inhibition of endothelial NO synthase (NOS) activity has been found to reverse the cardioprotective effects of H 2 S preconditioning in isolated rat cardiomyocytes by inhibiting cyclooxygenase-2 activity (Hu et al., 2008) .
In addition, NOS inhibitior-induced hypertension has been found to reduce plasma H 2 S concentration, vascular CSE activity, and mRNA expression in rats (Zhong et al., 2003 
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JPET #180711 (Terui et al., 1986; Verberne et al., 1999; Dampney et al., 2003) . Although previous studies indicate that the RVLM is a potential target for H 2 S to exert its role in the regulation of sympathetic vasomotor tone, no studies have determined the direct effects of H 2 S on this important cardiovascular center. Thus, the purpose of the current study was to investigate effect of microinjection of the H 2 S donor NaHS into the RVLM on sympathetic vasomotor tone and identify the possible underlying mechanisms.
This article has not been copyedited and formatted. The final version may differ from this version. 
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Methods
Animal
The experiments were performed on 48 male Sprague-Dawley rats (300 ± 5 g) obtained from the Experimental Animal Center of Hebei Province, China. All animal procedures were carried out in accordance with the National Institute of Health
Guidelines for animal research (1996) . All protocols and procedures were reviewed and approved by the Institutional Animal Care and Use Committee of Hebei Medical University.
Recording of Arterial blood pressure, Heart rate and Renal Sympathetic
Nerve Activity Rats were anesthetized with urethane (1.0 g/ kg i.p.) and their trachea was cannulated for ventilation. A thermostatic bed was used to maintain body temperature in the range of 37-38°C. The left femoral artery was cannulated to record arterial blood pressure (ABP) with a pressure transducer. The heart rate (HR) was measured by triggering from the pulsatile blood pressure. The left kidney was exposed via a retroperitoneal approach and a small branch of the left renal sympathetic nerve around the renal vessels was carefully isolated from the surrounding tissue and clamped distally to eliminate the nerve's afferent activity. The nerve was placed on a bipolar platinum electrode for potential recording and immersed in warm (37°C) mineral oil. The nerve signal was amplified (gain of Microinjection into the RVLM After the rat was anesthetized with urethane (1.0 g/kg i.p.), the rat was placed in a supine position, and the head of the animal was fixed on a stereotaxic frame. The trachea and esophagus were exposed through a midline incision and transected at the lower neck level and reflected rostrally. After retraction of the bilateral longus capitis muscles, the basilar portion of the occipital bone was removed to expose the ventral surface of the medulla with incision of the dura and arachnoid. We then coated the exposed medulla was covered with warm mineral oil and used a strip of thinly twisted cotton to constantly drain cerebrospinal fluid. The coordinates for RVLM were 1.9-2.3 mm lateral to the midline, 2.6-3.3 mm Protocols After a stable 30 min recording of ABP, HR, and RSNA was obtained, the vehicle solutions were microinjected into the RVLM. Subsequently, NaHS (4, 8, or 16 mmol/l, 50 nl) were microinjected into the RVLM, and ABP, HR, and RSNA were recorded. One dose was tested per rat.
We then investigated the effect of glibenclamide (40 µM, 50 nl) on the responses of ABP, HR, and RSNA to NaHS. We first determined whether a microinjection of NaHS (8 mM, 50 nl) into the RVLM produced a reproducible effect on the sympathetic vasomotor tone by performing identical microinjections of NaHS (8 mM, 50 nl) into the RVLM at 45 min intervals. ABP, HR, and RSNA returned to baseline levels within 45 min following the initial NaHS injection. After an initial microinjection of NaHS (8 mM, 50 nl), glibenclamide (40 µM, 50 nl) was microinjected into the RVLM. Ten minutes after glibenclamide injection, another dose of NaHS (8 mM, 50 nl) was injected into the RVLM. To determine whether NO was involved in the effect of NaHS on the sympathetic vasomotor tone, L-NAME (200 µM, 50 nl) was microinjected into the RVLM to inhibit NO synthesis. To determine whether Ca 2+ was involved in the 
JPET #180711
Statistical Analysis Data were expressed as means ± standard error (SE).
Differences between groups were analyzed using one-way analysis of variacnce (ANOVA), the Student-Newman-Kuels test, and Dunnett's t-test. P values < 0.05
were considered statistically significant. 
Effects of glibenclamide on NaHS-induced cardiovascular response We then determined the role of K ATP in the effect of NaHS (8 mM, 50 nl) on ABP, HR and RSNA. After tested the initial inhibitory effect of NaHS on ABP, HR and RSNA and these variables returned to baseline level, glibenclamide (40 µM, 50 nl) was microinjected into the RVLM followed by NaHS (8 mM, 50 nl) 10 min later in 6 rats.
Glibenclamide alone had no significant effect on ABP, HR, and RSNA but eliminated the inhibitory effect of NaHS on these cardiovascular variables (Figure 3 ). The vehicle used to dissolve glibenclamide (0.02 % DMSO in saline) showed no effect on ABP, HR, and RSNA.
Effect of L-NAME on the responses of ABP, HR, RSNA to NaHS. To determine if nitric oxide synthesis is involved in the effects of NaHS on sympathetic vasomotor tone, L-NAME was microinjected in to the RVLM. The initial NaHS microinjection into the RVLM significantly decreased the ABP from 100.35 mmHg to 82.98 mmHg (P < 0.01), HR from 423.5 bpm to 402.3 bpm (P < 0.01), and RSNA from 100 % to 66.49 % (P < 0.01). When L-NAME (200 µM, 50 nl) was microinjected into RVLM after ABP, HR, and RSNA returned to baseline levels, these variables showed no significant changes (Ma et al., 2008) . Subsequently, NaHS (8 mM, 50 nl) was microinjected again and ABP decreased from 99.19 to 92.56 mmHg (P < 0.01), HR from 426.33 bpm to 416.83bpm (P < 0.01), and RSNA from 100.00 % to 83.17% (P < 0.01) ( Figure   4 ). 
Effects of Bay K8644 on NaHS responses
To determine if Ca 2+ is involved in the responses of ABP, HR, and RSNA to NaHS mincroinjection into the RVLM, Bay K8644 was used. In 6 rats, after the initial effect of NaHS microinjection into the RVLM on the ABP, HR, and RSNA was determined, Bay K8644 (1 µM, 50 nl) was microinjected into the RVLM. ABP, HR, and RSNA did not change in response to Bay K8644 injection. Following the subsequent NaHS (8 mM, 50 nl) microinjection, ABP decreased from 103.89 to 92.4mmHg (P < 0.01), HR decreased from 418.5 bpm to 395.33 bpm (P < 0.05), and RSNA decreased from 100 % to 72.69 % (P < 0.01). And there is no significance was detected with the initial effect of NaHS microinjection into the RVLM (P > 0.05). (Figure 5 ).
Effects of HA on ABP, HR and RSNA
In addition, we determined the effect of blocking endogenous H 2 S synthesis on sympathetic vasomotor tone by microinjection of H 2 S synthesis inhibitor, HA (Abe and Kimura, 1996) . After microinjection of HA (30 mM, 50 nl) into the RVLM, ABP increased significantly from 96.96 ± 4.69 to 104.40 ± 5.05 mmHg (P < 0.01), HR increased significantly from 378.83 ± 18.30 to 387.17 ± 17.51 bpm (P < 0.01), and RSNA increased significantly from 100 ± 0 % to 120.98 ± 4.42 % (P < 0.01). The effect of HA started within 1 min, reached its peak within 5 min, and lasted for 10 to15 min ( Figure 6 ). 
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Discussion
To our knowledge, this is the first study to assess the role of H 2 S in the RVLM in the regulation of sympathetic vasomotor tone. We found that microinjection of NaHS into the RVLM decreased ABP, HR and RSNA in a dose-dependent manner. Blocking K ATP channels with glibenclamide abolished the sympathoinhibitory effects of NaHS;
and that preinjection of L-NAME to inhibit NO synthesis attenuated the H 2 S plays a physiological role in regulating cardiovascular functions (Xu et al., 2007; Ji et al., 2008; Xu et al., 2008) . For example, intravenous injection of H 2 S has been found to produce a transient but significant decrease in mean arterial blood pressure that is due to the relaxation of vascular smooth muscle cells (SMCs)
resulting from the opening of K ATP channels and the subsequent hyperpolarizing cell membranes of the SMCs of peripheral vessels (Zhao et al., 2001) . It is well known that the RVLM, which contains vasomotor neurons that project directly to sympathetic 
JPET #180711
preganglionic neurons in intermediolateral cell column in the spinal cord and play a pivotal role in the tonic and phasic regulation of sympathetic vasomotor tone (Dampney et al., 2002) . The inhibition of vasomotor neurons in this region leads to reduction of systemic arterial blood pressure and sympathetic outputs. In the current study, microinjection of the H 2 S donor, NaHS, into the RVLM decreased the ABP, HR, and RSNA in a dose-dependent manner, suggesting that H 2 S decreases the activity of vasomotor neurons in the RVLM. It has been shown that NaHS induces a concentration-dependent hyperpolarization and reduces input resistance of CA1 neurons and dorsal raphe neurons through activation of K ATP channels (Reiffenstein et al., 1992) . Furthermore, microinfusion of NaHS into the hypothalamus decreases arterial blood pressure in conscious rats, an effect that is blocked by K ATP channel blocker (Dawe et al., 2008) . These findings indicate that K ATP channels are importantly involved in the action of H 2 S in the central nervous system. Consistent with those findings, in the current study, we found that pretreatment with glibenclamide, a K ATP channel blocker, abolished the effects of H 2 S on ABP, HR, and RSNA, which suggests that the sympathoinhibitory effects of H 2 S in the RVLM occur via the opening of K ATP channels. 
channel complex (Jiang et al.) . Furthermore, direct chemical modification of the rvSUR1 subunit protein constitutes a molecular mechanism for the activation of K ATP channels by H 2 S (Jiang et al.) . Therefore, the H 2 S signaling pathways that interact with K ATP channels are potentially involve the modulation of the rvSUR1 subunit of K ATP channels in the sympathetic vasomotor neurons in the RVLM.
Previous studies have shown that NO donor treatment enhances the endogenous production of H 2 S in rat aortic tissues by increasing the activity and expression of CSE (Zhao et al., 2001) , suggesting that H 2 S and NO interact to facilitate relaxation of vascular smooth muscle (Hosoki et al., 1997) . In this regard, pretreatment with the NOS inhibitor L-NAME attenuates NaHS-induced cardioprotection following metabolic inhibition preconditioning (Pan et al., 2006) . Consistent with those findings, in the current study, we found that pretreatment with L-NAME attenuated the inhibitory effects of H 2 S on sympathetic vasomotor tone. These data suggest that it is likely that NO synthesis is involved in the sympathoinhititory action of H 2 S in the RVLM. This notion is supported by the findings that NO can activates K ATP channels in large dorsal root ganglion neurons via direct S-nitrosylation of cysteine residues in the SUR1 subunit (Kawano et al., 2009) . Furthermore, NOS is expressed in the RVLM (Chan et al., 2004) .
It has been shown that H 2 S increases the sensitivity of carotid sinus baroreflex by opening K ATP channels and closing of the L-type Ca 2+ channels (Xiao et al., 2006; Xiao et al., 2007 
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JPET #180711 (Li et al., 1998 ). In the current study, however, we found that an L-type Ca 2+ channel opener, Bay K8644, failed to change the inhibitory effects of H 2 S on ABP, HR and RSNA, which suggests that L-type Ca 2+ channels may not be involved in the sympathoinhibitory effect of H 2 S in the RVLM.
Because H 2 S production from cysteine by brain homogenates was strongly inhibited by the CBS inhibitors HA and aminooxyacetate (Abe and Kimura, 1996) , we determined the role of endogenous H 2 S in the regulation of basal sympathetic vasomotor tone. We found that microinjection of HA into the RVLM significantly increased ABP, HR, and RSNA. These data suggest that endogenous H 2 S tonically inhibits sympathetic vasomotor tone. Previous studies have shown that HA acts as an NO donor to release NO (Gerova et al., 1995) and increase γ-aminobutyric acid (GABA) level (Czajka, 1978) . However, infusions of NO donor sodium nitroprusside and GABA into the RVLM have both been shown to decrease sympathetic nerve activity (Yang et al., 1996; Heesch et al., 2006 ). In the current study, however, microinjection of H 2 S into the RVLM induced an increase in ABP, HR and RSNA.
Therefore, it is unlikely that the effect of HA in the RVLM was not mediated by NO and GABA. In addition, we found that CBS immunoreactivity-positive neurons were evenly distributed in the RVLM. Although we did not identify the subpopulation of neurons in the heterogeneous RVLM region, it is expected that at least a portion of CBS-positive neurons were vasomotor neurons. Moreover, because H 2 S is a small gaseous molecule that can diffuse freely at a certain distance 
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JPET #180711 (Reiffenstein et al., 1992) . Its action on the vasomotor neurons can occur without CBS expression. Thus, the expression of CBS in the RVLM provides additional evidence that endogenous H 2 S tonically exerts an inhibitory effect on sympathetic outflow.
In summary, findings from the current study provide strong evidence that H 2 S inhibits sympathetic vasomotor tone in the RVLM and that endogenous H 2 S is involved in the regulation of basal sympathetic outflow. These data suggest that H 2 S is a novel therapeutic target that can be manipulated to reduce the sympathetic outflow in certain cardiovascular diseases that have with heightened sympathetic activity.
This article has not been copyedited and formatted. The final version may differ from this version. Data are means ± SE. **: P <0.01 compared with control value; ↓, microinjection of NaHS. 
